BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $86,597,000 | +3.4% | 572,845 | -0.3% | 0.02% | +11.1% |
| Q2 2022 | $83,749,000 | +34.1% | 574,770 | +9.2% | 0.02% | +63.6% |
| Q1 2022 | $62,433,000 | -22.1% | 526,552 | -9.4% | 0.01% | -15.4% |
| Q4 2021 | $80,132,000 | +3.7% | 581,474 | +4.5% | 0.01% | -7.1% |
| Q3 2021 | $77,261,000 | +42.1% | 556,193 | -0.7% | 0.01% | +40.0% |
| Q2 2021 | $54,352,000 | +47.1% | 559,865 | +3.6% | 0.01% | +42.9% |
| Q1 2021 | $36,946,000 | -22.9% | 540,542 | -3.3% | 0.01% | -22.2% |
| Q4 2020 | $47,910,000 | +29.0% | 558,974 | -2.1% | 0.01% | +12.5% |
| Q3 2020 | $37,129,000 | -13.4% | 571,119 | -2.6% | 0.01% | -20.0% |
| Q2 2020 | $42,887,000 | +140.1% | 586,616 | +11.8% | 0.01% | +100.0% |
| Q1 2020 | $17,859,000 | -30.9% | 524,792 | +10.5% | 0.01% | -16.7% |
| Q4 2019 | $25,850,000 | +26.5% | 474,843 | -3.1% | 0.01% | +20.0% |
| Q3 2019 | $20,436,000 | +17.0% | 489,849 | +22.9% | 0.01% | +25.0% |
| Q2 2019 | $17,460,000 | -11.9% | 398,721 | +3.5% | 0.00% | -20.0% |
| Q1 2019 | $19,822,000 | +55.1% | 385,108 | +11.4% | 0.01% | +25.0% |
| Q4 2018 | $12,780,000 | -1.7% | 345,633 | -0.2% | 0.00% | +33.3% |
| Q3 2018 | $13,002,000 | +1.6% | 346,269 | +6.9% | 0.00% | 0.0% |
| Q2 2018 | $12,802,000 | +63.6% | 323,923 | +6.6% | 0.00% | +50.0% |
| Q1 2018 | $7,827,000 | +146.8% | 303,830 | +158.5% | 0.00% | +100.0% |
| Q4 2017 | $3,172,000 | -27.7% | 117,556 | +0.1% | 0.00% | 0.0% |
| Q3 2017 | $4,389,000 | +55.3% | 117,408 | +3.9% | 0.00% | 0.0% |
| Q2 2017 | $2,826,000 | – | 113,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |